Enabling structure-based drug design of Tyk2 through co-crystallization with a stabilizing aminoindazole inhibitor
通过与稳定氨基吲唑抑制剂共结晶，实现基于结构的Tyk2药物设计。
期刊:BMC Structural Biology
影响因子:
doi:10.1186/1472-6807-12-22
Argiriadi, Maria A; Goedken, Eric R; Banach, David; Borhani, David W; Burchat, Andrew; Dixon, Richard W; Marcotte, Doug; Overmeyer, Gary; Pivorunas, Valerie; Sadhukhan, Ramkrishna; Sousa, Silvino; Moore, Nigel St John; Tomlinson, Medha; Voss, Jeffrey; Wang, Lu; Wishart, Neil; Woller, Kevin; Talanian, Robert V
